BioXcel Therapeutics Inc (BTAI)

30.86 +0.96  +3.23% NASDAQ Oct 26, 16:00 30.86 0.00  0.00% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All BTAI News

News

View All Events

Events

Date Type Description
11/12/2021 Earnings Results Q3 2021 Earnings Results
11/12/2021 08:30 EST Earnings Calls Q3 2021 Earnings Call
08/10/2021 Earnings Results Q2 2021 Earnings Results
08/10/2021 08:30 EST Earnings Calls Q2 2021 Earnings Call
06/11/2021 09:00 EST AGM 2020 Annual General Meeting
05/10/2021 Earnings Results Q1 2021 Earnings Results
05/10/2021 08:30 EST Earnings Calls Q1 2021 Earnings Call
03/11/2021 Earnings Results Q4 2020 Earnings Results
03/11/2021 08:30 EST Earnings Calls Q4 2020 Earnings Call
11/12/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501, and BXCL701.
  • URL: https://www.bioxceltherapeutics.com
  • Investor Relations URL: N/A
  • HQ State/Province: Connecticut
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 12, 2021
  • Last Earnings Release: Aug. 10, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A

Top Fund Holders

Symbol Name Weighting
F000016ZDA ST Healthcare Innovations 11 F RE 3.46%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.